|Mr. Uwe Röhrhoff||Chairman of Management Board and Chief Exec. Officer||1.5M||N/A||55|
|Mr. Rainer Beaujean||Chief Financial Officer and Member of the Management Board||2.29M||N/A||49|
|Mr. Andreas Schutte||Member of the Management Board||1.24M||N/A||55|
|Ms. Katja Mögel||Group Director Bus. Excellence & Continuous Improvement and Member of the Supervisory Board||57.78k||N/A||36|
|Ms. Severine Camp||Corp. Sr. Director of Investor Relations||N/A||N/A||N/A|
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices. This division also provides containers for the delivery of tablets and powder, liquid dosage, ophthalmic and rhinological applications, parenteral packaging applications, and oral prescription medication. The Primary Packaging Glass division offers glass primary packaging for medicines and cosmetics, such as ampoules, cartridges, vials and syringe barrels, syrup and dropper bottles, tablet jars, wide-neck jars, as well as injection, infusion, and transfusion bottles; flacons and pots for fragrances, deodorants, care and decorative cosmetics; and specialty containers for spirits and food. Gerresheimer AG was founded in 1864 and is headquartered in Düsseldorf, Germany.
Gerresheimer AG’s ISS Governance QualityScore as of July 1, 2017 is 2. The pillar scores are Audit: 5; Board: 1; Shareholder Rights: 1; Compensation: 2.